We are live on
!
Find out more
DIC
Deer IX & Co Portfolio holdings
AUM
$971M
1-Year Est. Return
24.77%
This Fund
S&P 500
This Quarter
Est. Return
-31.86%
1 Year Est. Return
-24.77%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$971M
AUM Growth
-$134M
(-12%)
Cap. Flow
+$504M
Cap. Flow
% of AUM
51.89%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
4
Increased
–
Reduced
1
Closed
1
Top Buys
| 1 |
VLD
Velo3D, Inc.
VLD
|
+$375M |
| 2 |
OTMO
Otonomo Technologies Ltd. Ordinary shares
OTMO
|
+$123M |
| 3 |
Spire Global
SPIR
|
+$76.6M |
| 4 |
TScan Therapeutics
TCRX
|
+$11.6M |
Top Sells
| 1 |
nCino
NCNO
|
+$46.8M |
| 2 |
Kymera Therapeutics
KYMR
|
+$35.9M |
Sector Composition
| 1 | Healthcare | 53.56% |
| 2 | Industrials | 37.81% |
| 3 | Technology | 8.62% |
Similar funds
WAM
CCP
AC
KFM
OAM
SIM
LBD
FMT
Deer IX & Co's Q3 2021 Portfolio in Review
As of Q3 2021, Deer IX & Co held 7 positions worth $971M, down 12% from $1.11B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Deer IX & Co deployed $504M of net new capital in Q3 2021, opening 4 new positions. Its largest new stake was Velo3D, Inc.: 1,081,835 shares worth $285M.
By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 96% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Kymera Therapeutics, an estimated $35.9M trimmed.
- Deer IX & Co's largest Q3 2021 buy was Velo3D, Inc.: 1,081,835 shares worth $285M.
- Deer IX & Co's biggest Q3 2021 reduction was Kymera Therapeutics, cutting an estimated $35.9M.
- Deer IX & Co fully exited nCino in Q3 2021, selling an estimated $46.8M.
- Deer IX & Co's ten largest holdings make up 100% of its $971M portfolio in Q3 2021.
- Deer IX & Co opened 4 new positions and closed 1 in Q3 2021.
- Deer IX & Co's portfolio value fell 12% quarter-over-quarter to $971M.
Based on Deer IX & Co's 13F filing for Q3 2021, filed 15 Nov 2021.